These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 16362889)

  • 1. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels.
    Kumar A; Haery C; Paladugu B; Kumar A; Symeoneides S; Taiberg L; Osman J; Trenholme G; Opal SM; Goldfarb R; Parrillo JE
    J Infect Dis; 2006 Jan; 193(2):251-8. PubMed ID: 16362889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac output and organ blood flow in experimental septic shock: effect of treatment with antibiotics, corticosteroids, and fluid infusion.
    Ottosson J; Dawidson I; Brandberg A; Idvall J; Sandor Z
    Circ Shock; 1991 Sep; 35(1):14-24. PubMed ID: 1742857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.
    Starnes HF; Pearce MK; Tewari A; Yim JH; Zou JC; Abrams JS
    J Immunol; 1990 Dec; 145(12):4185-91. PubMed ID: 2124237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock.
    Freeman BD; Yatsiv I; Natanson C; Solomon MA; Quezado ZM; Danner RL; Banks SM; Hoffman WD
    J Am Coll Surg; 1995 Mar; 180(3):286-92. PubMed ID: 7874338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
    Chatterjee S; Premachandran S; Shukla J; Poduval TB
    J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.
    Sevransky JE; Shaked G; Novogrodsky A; Levitzki A; Gazit A; Hoffman A; Elin RJ; Quezado ZM; Freeman BD; Eichacker PQ; Danner RL; Banks SM; Bacher J; Thomas ML; Natanson C
    J Clin Invest; 1997 Apr; 99(8):1966-73. PubMed ID: 9109441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
    Creasey AA; Chang AC; Feigen L; Wün TC; Taylor FB; Hinshaw LB
    J Clin Invest; 1993 Jun; 91(6):2850-60. PubMed ID: 8514893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of some drugs on the levels of selected cytokines in experimental septic shock].
    Ladny JR; Dzienis H; Dadan J; Polaków J; Venskutonis D; Puchalski Z
    Wiad Lek; 1997; 50 Suppl 1 Pt 2():247-51. PubMed ID: 9424882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    Clin Microbiol Infect; 2006 Nov; 12(11):1105-11. PubMed ID: 17002610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock.
    Lechner AJ; Rouben LR; Potthoff LH; Tredway TL; Matuschak GM
    Circ Shock; 1993 Apr; 39(4):306-15. PubMed ID: 8485822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis.
    Hiromatsu T; Yajima T; Matsuguchi T; Nishimura H; Wajjwalku W; Arai T; Nimura Y; Yoshikai Y
    J Infect Dis; 2003 May; 187(9):1442-51. PubMed ID: 12717626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protective effect of ketamine against septic shock in rats].
    Song XM; Li JG; Wang YL; Zhou Q; Du ZH; Jia BH; Hu ZF; Li P
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jun; 16(6):348-51. PubMed ID: 15182446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid resuscitation in severe sepsis and septic shock: albumin, hydroxyethyl starch, gelatin or ringer's lactate-does it really make a difference?
    Su F; Wang Z; Cai Y; Rogiers P; Vincent JL
    Shock; 2007 May; 27(5):520-6. PubMed ID: 17438457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.
    Lally KP; Cruz E; Xue H
    J Pediatr Surg; 2000 Jun; 35(6):852-4; discussion 855. PubMed ID: 10873025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of somatostatin on serum interleukin-6 and tumor necrosis factor-alpha in lipopolysaccharide-induced septic shock: experiment with rats].
    Zhu TJ; Dong GR; Huang GQ; Fan XP; Liu B; Zhang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):345-7. PubMed ID: 17456366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock.
    Humes HD; Buffington DA; Lou L; Abrishami S; Wang M; Xia J; Fissell WH
    Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome.
    Manley MO; O'Riordan MA; Levine AD; Latifi SQ
    Shock; 2005 Jun; 23(6):521-6. PubMed ID: 15897804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
    Matsuda T; Freeman TA; Hilbert DW; Duff M; Fuortes M; Stapleton PP; Daly JM
    Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-inflammatory activity of clarithromycin inhibits TNFalpha production and prolongs survival following lipopolysaccharide administration in mice.
    Tkalcević VI; Bosnjak B; Pasalić I; Hrvacić B; Situm K; Kramarić MD; Glojnarić I; Eraković Haber V
    Int J Antimicrob Agents; 2008 Aug; 32(2):195-6. PubMed ID: 18571382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.